Although excessively long bleeding times and increased incidence of hemorrhagic stroke have been observed in Greenland Eskimos with very high intakes of EPA + DHA (6.5 g/day), it is not known whether high intakes of EPA and DHA are the only factor responsible for these observations (1)
It depends on whether your plan includes physician oversight or just a prescription
A.SoonI
GLP-1 Market Segmentation By Type of Molecule Outlook (Revenue, USD Billion, 20212034) Biologics Small Molecules By Active Compound Used Outlook (Revenue, USD Billion, 20212034) Dulaglutide Liraglutide Orforglipron Retatrutide Semaglutide Survodutide Tirzepatide Other Active Compounds By Type of GLP-1 Agonist Drugs Outlook (Revenue, USD Billion, 20212034) Long-acting GLP-1 Agonist Short-acting GLP-1 Agonist By Route of Administration Outlook (Revenue, USD Billion, 20212034) Oral Parenteral By Target Indication Outlook (Revenue, USD Billion, 20212034) Alzheimers Disease Non-Alcoholic Steatohepatitis Obesity Sleep Apnea Type 2 Diabetes By Regional Outlook (Revenue, USD Billion, 20212034) North America U.S
On the other hand, individuals with type 2 diabetes or those who have struggled with weight loss despite other interventions may find GLP-1 medications beneficial

Studies show that supplemental melatonin changes the composition of the gut microbiome, reduces weight, decreases fatty liver, and decreases low-grade inflammation.[ref] Another animal study showed that melatonin not only changes the gut microbiome but also improves the intestinal barrier and increases gastrointestinal motility.[ref] Viral and parasitic infections: Cardiomyopathy, caused by a viral infection (Coxsackievirus B3), is prevented by supplemental melatonin.[ref] Quite a few parasitic infections show improvement with melatonin including malaria, toxoplasmosis, and trypanosomiasis.[ref] Pretreatment with melatonin decreases the damage to the lungs in RSV infection.[ref] Melatonin may even help with the Ebola virus.[ref] Migraines: A randomized placebo-controlled trial showed that melatonin (3mg/night) for 12 weeks was superior to placebo for migraine prevention